Condition: Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma · Sponsor: Bristol-Myers Squibb
The purpose of this study is to evaluate the safety and efficacy of Pumitamig in combination with chemotherapy versus Nivolumab in combination with chemotherapy in participants with previously untreated advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Local Institution - 0284 | Phoenix, Arizona, United States | Not Yet Recruiting |
| Local Institution - 0437 | Los Angeles, California, United States | Not Yet Recruiting |
| University of California, Irvine (UCI) Health - UC Irvine Medical Center | Orange, California, United States | Recruiting |
| Local Institution - 0428 | San Francisco, California, United States | Not Yet Recruiting |
| Florida Cancer Specialists - South | Fort Myers, Florida, United States | Recruiting |
| Local Institution - 0433 | Jacksonville, Florida, United States | Not Yet Recruiting |
| Florida Cancer Specialists - North | St. Petersburg, Florida, United States | Recruiting |
| Local Institution - 0246 | Tampa, Florida, United States | Not Yet Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Local Institution - 0379 | Chicago, Illinois, United States | Not Yet Recruiting |
| Local Institution - 0268 | Iowa City, Iowa, United States | Not Yet Recruiting |
| Local Institution - 0259 | Rochester, Minnesota, United States | Not Yet Recruiting |
+ 149 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07221149